通过微量测定法测定脑膜炎球菌抗体。
Determination of meningococcal antibodies by microassay.
作者信息
Ambrosch F, Stemberger H, Wiedermann G, Stanek G, Jovanovic D
出版信息
Bull World Health Organ. 1978;56(5):787-90.
Abstract
A modified microassay procedure, using triphenyltetrazolium chloride as a germination indicator, was compared with a macroassay method proposed by the World Health Organization for determining the level of antibodies before and after immunization with Group A meningococcal polysaccharide vaccine. There was excellent agreement between the results obtained by the two methods. The vaccine used appeared to be safe and immunogenic.
摘要
一种改良的微量测定方法，使用氯化三苯基四氮唑作为发芽指示剂，与世界卫生组织提出的用于测定A群脑膜炎球菌多糖疫苗免疫前后抗体水平的常量测定方法进行了比较。两种方法所得结果之间具有极好的一致性。所用疫苗似乎是安全且具有免疫原性的。
相似文献
1
Determination of meningococcal antibodies by microassay.通过微量测定法测定脑膜炎球菌抗体。
Bull World Health Organ. 1978;56(5):787-90.
2
[Immunity against Neisseria meningitidis in different population groups].不同人群中针对脑膜炎奈瑟菌的免疫力
Rev Cubana Med Trop. 1989 Jan-Apr;41(1):135-47.
3
Serum antibodies to capsular polysaccharide vaccine of group A and C Neisseria meningitidis in military recruits in Italy.意大利新兵中A群和C群脑膜炎奈瑟菌荚膜多糖疫苗的血清抗体情况
Allergol Immunopathol (Madr). 1991 Jan-Feb;19(1):39-41.
4
Immunogenicity and side-effects of a new tetravalent meningococcal polysaccharide vaccine.一种新型四价脑膜炎球菌多糖疫苗的免疫原性和副作用
Bull World Health Organ. 1983;61(2):317-23.
5
6
The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.B群脑膜炎奈瑟菌的荚膜多糖作为疫苗开发的载体。
Contrib Microbiol Immunol. 1989;10:151-65.
7
Complex of meningococcal group B polysaccharide and type 2 outer membrane protein immunogenic in man.B群脑膜炎球菌多糖与2型外膜蛋白复合物在人体中具有免疫原性。
J Clin Invest. 1979 May;63(5):836-48. doi: 10.1172/JCI109383.
8
Review of meningococcal vaccines with emphasis on possible immunoprophylaxis of group B disease.脑膜炎球菌疫苗综述，重点关注B群疾病的可能免疫预防。
NIPH Ann. 1980 Dec;3(2):67-74.
9
Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine.脑膜炎球菌C多糖疫苗会在成人中引发免疫低反应性，而脑膜炎球菌C结合疫苗可克服这一情况。
J Infect Dis. 2000 Feb;181(2):761-4. doi: 10.1086/315284.
10
[Serological evaluation of polyvalent A-C anti-meningococcal vaccine in Chile].[智利A-C多价抗脑膜炎球菌疫苗的血清学评估]
Bol Oficina Sanit Panam. 1982 Aug;93(2):149-57.
引用本文的文献
1
Immunogenicity and side-effects of a new tetravalent meningococcal polysaccharide vaccine.一种新型四价脑膜炎球菌多糖疫苗的免疫原性和副作用
Bull World Health Organ. 1983;61(2):317-23.
本文引用的文献
1
Meningococcal infections. 4. Stability of group A and group C polysaccharide vaccines.脑膜炎球菌感染。4. A群和C群多糖疫苗的稳定性。
Bull World Health Organ. 1971;45(3):287-90.
2
Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants.A群和C群脑膜炎球菌多糖疫苗在婴儿中的临床评估
J Clin Invest. 1975 Dec;56(6):1536-47. doi: 10.1172/JCI108235.
3
Clinical and laboratory investigations of monovalent and combined meningococcal polysaccharide vaccine, groups A and C.A群和C群单价及联合脑膜炎球菌多糖疫苗的临床与实验室研究
Proc Soc Exp Biol Med. 1976 Dec;153(3):436-40. doi: 10.3181/00379727-153-39563.
4
Effect of group-A meningococcal vaccine in army recruits in Finland.A群脑膜炎球菌疫苗对芬兰新兵的影响。
Lancet. 1975 Nov 8;2(7941):883-6. doi: 10.1016/s0140-6736(75)92125-x.
Zotero 插件